SCNX
Scienture Holdings, Inc.Company with tickers: SCNX
CIK
1382574
CUSIP
80880X104
Shares Outstanding
40,630,815
13F Activity (30d)
9 filings
9 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $56,325 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | $56,325 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | $2,475 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Gross Profit | $53,850 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $3,563,349 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $793,984 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-3,509,499 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-3,402,264 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |